A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently
| Image |  |
|---|---|
| Description | scientific article published on 16 November 2019 |
| Author/s |
author: Merlin Thomas Gary Wittert David Simmons |
| Publication date | November 16, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |